News
![novartis innit](https://pharmaphorum.com/wp-content/uploads/2019/10/novartis-innit.jpg)
NICE says yes to Novartis' Rydapt for rare blood disorder
Novartis' Rydapt has become the first and only licensed treatment for rare and life-threatening blood disorder systemic mastocytosis (SM) to be cleared for routine NHS use, after getting a